Clinical presentation, diagnosis and management of <i>Cryptococcus gattii</i> cases: Lessons learned from British Columbia, Pulsus Group Inc
       
  Pulsus Group Inc. The Medical Peer Review Publisher
                                                                                                                       
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
  Search The Canadian Journal of Infectious Diseases & Medical Microbiology
Search    
Advanced Search PROFESSIONAL SITE
CONSUMER SITE
 
 
 
 
THE CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY
Association of Medical Microbiology & Infectious Diseases (AMMI Canada)
                                                                                   
                                                                                   
                                                                                   
 
   Home   
   Current Issue   
   Past Issues   
   Guidelines   
   Supplements   
   Submit Manuscript   
   Calendar   
   Links   
 
 
 
Return to TOC
   PDF / Free   
 
Case Report Spring 2009, Volume 20 Issue 1: 23-28
 
Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia
E Galanis, L Hoang, P Kibsey, M Morshed, P Phillips

The environmental fungus Cryptococcus gattii emerged on Vancouver Island, British Columbia (BC), in 1999. By the end of 2006, it led to 176 cases and eight deaths - one of the highest burdens of C gattii disease worldwide. The present paper describes three cases, and the BC experience in the diagnosis and management of this infection. All three cases presented with pulmonary findings, including cryptococcomas and infiltrates. One also presented with brain cryptococcomas. Cases were diagnosed by chest and brain imaging, and laboratory evidence including serum or cerebrospinal fluid cryptococcal antigen detection and culture of respiratory or cerebrospinal fluid specimens. Genotyping of fungal isolates confirmed infection with C gattii VGIIa. Pulmonary cases were treated with fluconazole. One patient with central nervous system disease was treated with amphotericin B followed by fluconazole. Although this infection remains rare, clinicians should be aware of it in patients with a compatible clinical presentation who are either living in or returning from a trip to BC.

   Français        E-Mail This Abstract To A Colleague
            Click here to download free Adobe PDF Reader
 
 
 
 
  Log in
  Register
  Sign up for eTOC
  Survey
  Shopping Cart
Copyright © Pulsus Group Inc